Corindus Vascular Robotics to Report Third Quarter 2016 Financial Results on November 8, 2016 | Business Wire
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer
of precision vascular robotics, today announced that it'll
release financial and business results for the third quarter 2016 after
the close of trading on Tuesday, November 8, 2016. The Company’s
management team will host a corresponding conference call beginning at
4:30 p.m. ET to discuss the financial results and recent business
Investors interested in listening to the conference call may do so by
DUBLIN--(BUSINESS WIRE)--The "Recent Developments in Coatings" report has been added to Research and Markets' offering.
This issue of the Advanced Coatings and Surface Technology TOE profiles research studies related to the development of water repellant and anti-fouling coatings.
The issue also profiles innovations focused on water borne coatings that are commercialized for use in extreme temperature and operating conditions and also a composite coating intended for metal substrates.
The Advanced Coating & Surface Technology TechVision Opportunity Engine (TOE) provides intelligence on technologies, products, processes, applications and strategic insights on various coatings across industries.
This encompasses protective and functional coatings such as antimicrobial coatings, food coatings, energy-saving coatings, smart glazing, hydrophilic, hydrophobic and super hydrophobic coatings, corrosion protection coatings, barrier coatings and paints.
The Chemicals and Advanced Materials cluster tracks research & innovation trends and developments across specialty chemicals, plastics, polymers, chemicals, bio-chemicals, metals, coatings, thin films,...
dialling (877) 201-0168 for domestic callers or (647) 788-4901 for
international callers (Conference ID: 97286733). From the webcast on
the “Investor Relations” section of the Company’s website at: www.corindus.com.
Following the call, an audio replay will be available on the Investor
Relations section of the Company’s website.
About Corindus Vascular Robotics, Inc.
Vascular Robotics, Inc. is a global technology leader in
robotic-assisted vascular interventions. The company’s CorPath®
System is the first FDA-cleared medical device to bring robotic-assisted
precision to radial, coronary and peripheral procedures. During the
procedure, the interventional cardiologist sits at a radiation-shielded
workstation to advance stents and guidewires with
millimeter-by-millimeter precision. The workstation allows the physician
greater control and the freedom from wearing heavy lead protective
equipment that causes musculoskeletal injuries. With the CorPath System,
Corindus Vascular Robotics brings robotic precision to radial and
complex interventional procedures to help optimise clinical outcomes and
minimise the costs associated with complications of improper stent
placement with manual procedures. Corindus stands behind its product
with its unique $1,000 hospital credit “One Stent Program.”
For additional information, visit www.corindus.com,
and follow @CorindusInc.